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Latin America and the Caribbean (LAC) has a pop-
ulation of more than 650 million inhabitants (8.5% of
the world population),1 with a cancer incidence of
more than 1.4 million new patients and more than
670,000 deaths in 2018. These figures will increase by
78% by 2040 to more than 2.5 million people di-
agnosed with cancer each year, and these patients will
requiremedical attention, care, and support. However,
many of these new cancer diagnoses can be pre-
vented through public policies, supportive environ-
ments, and lifestyles that promote health and prevent
cancer (Fig 1).2 In the LAC region, there are many
organizations and institutions providing information on
cancer prevention, including national cancer in-
stitutes, cancer societies and foundations, and public
health agencies. Nevertheless, the information is fre-
quently confusing, overwhelming, or even contradic-
tory. The scientific source and credibility, as well as the
primary message, differ according to the type of or-
ganization that provides the information (eg, patient
organization, scientific or governmental institution).
The International Agency for Research on Cancer
(IARC), the agency of the WHO that specializes in
cancer, has led a European Union initiative to update
the European Code Against Cancer, providing an
authoritative source of advice to individual citizens on
how to reduce the cancer risks by means of 12
recommendations.3,4 The European Code Against
Cancer was based on the evaluation of the latest
scientific evidence by leading scientists from across
Europe and tailored to the cancer situation in Euro-
pean populations. The provision of such science-
based recommendations as a key cancer prevention
tool is critical to inform people and guide health ed-
ucation to promote healthy behaviors and support the
development of public policies. However, to be ex-
tended to other regions under the framework of
a World Code Against Cancer,5 the recommenda-
tions should be adapted to specific cancer patterns,
associated risk factors, cultural characteristics, and
health systems capacity. The impact of the European
Code resulted in national promotion and dissemination
activities coordinated by the Association of European
Cancer Leagues,6 and in addition, several European
countries have adopted the structure proposed by the
European Code in their respective comprehensive
National Cancer Plans, in some cases even including
specific objectives for each of the recommendations of
the Code.7
For the LAC region, a coalition of institutions and in-
ternational organizations has joined forces to adapt the
European Code to the cancer risks and situation in the
LAC region. This involves collecting, analyzing, and
evaluating the scientific evidence to support suit-
able cancer prevention recommendations to the LAC
context. A multistakeholder participation in the project
is a key approach to ensure that all players will be
owners of the Code and true promoters. The coalition is
composed of the Pan-American Health Organization
(PAHO; also part of the WHO) and the IARC as leading
international organizations; a Scientific Committee of
senior researchers and distinguished leaders in cancer
prevention from LAC; and an Advocacy Group rep-
resenting important organizations in LAC, including
the Latin American and Caribbean Society of Medical
Oncology, the Network of Latin-American Cancer In-
stitutes, the Healthy Caribbean Coalition, and the
Association of Latin American Leagues Against Can-
cer. With financial support of IARC and PAHO, the
coalition met first in April 2017 and again in Lima,
Peru, in June 2018.
Under the scientific leadership of IARC and the sec-
retariat of PAHO, the coalition nominated the pre-
viously mentioned Scientific Committee to adopt the
IARC methodology with the purpose of developing
recommendations for the LAC region, similarly to the
process followed by the development of the European




















Downloaded from ascopubs.org by 181.46.145.228 on June 27, 2019 from 181.046.145.228
Copyright © 2019 American Society of Clinical Oncology. All rights reserved.
IARC and PAHO, experts from LAC in epidemiology, life-
styles, environmental and occupational risks, infections,
medical interventions, and communication plan to define
cancer prevention priorities and develop a set of region-
specific, evidence-based recommendations and supple-
mentary information founded on the best available and
most recent scientific evidence on causes of cancer and
their prevention, reflecting the social, economic, and en-
vironmental determinants of cancer in LAC. The recom-
mendations and related additional information would then
be approved by the Scientific Committee to secure the
highest acceptance and ownership by both the public and
those working in the health system and advising on public
health. The end product would be a set of cancer pre-
vention messages directed to the general public and to
health providers in Spanish, Portuguese, and English and
delivered to the Ministries of Health in the respective LAC
countries. These recommendations, adapted to the specific
needs of the region, will complement national cancer
control plans and strategies and become an effective tool to
reduce the risks for cancer.8
FINAL WORDS
Latin America struggles with huge disparities in health
system capacity to address the growing burden of cancer
and other noncommunicable diseases, especially among
smaller economies of the Caribbean and Central America9.
The conspicuous scarcity of trained specialists coupled
with the absence of resources for a robust primary care
structure result in late diagnosis and higher rates of ad-
vanced, often incurable disease. The Code is urgently
needed to stimulate public policy and health system
changes toward cancer prevention and as an instrument
that has a broad impact on diverse populations and is
applicable irrespective of the status of the health care
system.
This collaborative project among LAC partners will improve
cancer control through the following ways: by promoting
effective communication of current critically appraised and
scientifically validated evidence on clear messages for
cancer prevention; by stimulating the empowering of the
individual and the community while offering a good
framework for cancer prevention education programs; by
offering a strong evidence base and data on cancer risks
and burden to adapt recommendations to the LAC region;
by facilitating ownership and political impact through the
endorsement of the countries of a region; and by providing
a united voice to call for cancer prevention under consistent
messages and sustain them over the long term.
It is guaranteed that a united and powerful voice, supported
by leading regional and international cancer and public
health organizations, with data based on the latest scientific
evidence and originated in the region, will be extraordinarily
helpful for cancer prevention. In addition, a clear guide for
the public, health care providers, policymakers, and gov-
ernments will be highly valuable. In addition, this example
of collaboration will serve as amodel of collaborative project
development in the LAC region.
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FIG 1. Projected cancer incidence and deaths from cancer in
2018 and in 2040 in Latin America and the Caribbean.
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